Our Milestones

Pharmacist Erol Toksöz founded Galenos Pharmaceutical Warehouse in Ankara.

The acquisition of Adilna marked a significant step in Sanovel's growth within the Turkish pharmaceutical industry.

Sanovel was founded, beginning a journey of innovation and growth.

Sanovel launched its leading brands, Lansor and Majezik.

Construction began on our state-of-the-art manufacturing facility in Silivri, İstanbul.

Sanovel entered international markets, launching its export operations.

Our manufacturing facility received EU GMP certification from the German health authority.

Sanovel ranked among the Top 15 pharmaceutical companies worldwide in terms of European patent applications and expanded into the European market.

Our manufacturing facility received EU GMP certification from the Spanish Agency for Medicines and Medical Devices (AEMPS). Sanovel was also recognized as Türkiye's No. 1 pharmaceutical R&D center in Intellectual Property Competency, and he leading private-sector pharmaceutical R&D center at the Private Sector R&D Centers Summit.

Sanovel received approval from the U.S. Food and Drug Administration (FDA) and the Russian Ministry of Health

Our export operations expanded across the CIS region, Europe, Africa, the Middle East and the United States. The World Intellectual Property Organization (WIPO) ranked Sanovel No. 2 in Türkiye for international patent applications, and o. 1 in the Turkish pharmaceutical industry.

Sanovel once again ranked 15th worldwide in the Pharmaceuticals category in the European Patent Office's list of companies with the highest number of patent applications.

Sanovel once again ranked 15th worldwide in the Pharmaceuticals category in the European Patent Office's list of companies with the highest number of patent applications

Sanovel celebrated its 40th anniversary. According to Türkiye's Patent Report 2022, Sanovel ranked 1st in the Turkish pharmaceutical industry, and 3rd among all industries based on cumulative European patent applications. Following a successful inspection, Sanovel received its second FDA approval.

According to the European Patent Office 2023 data, Sanovel ranked 18th worldwide in the Pharmaceuticals category among the Top 25 Patent Applicants, becoming the only Turkish company included in the list. Sanovel was also named a Finalist in the Leadership in Human Value (Grand Award) category at the PERYÖN Human Value Awards.

According to Türkiye's Patent Report 2024, Sanovel ranked 1st in the pharmaceutical industry among European patent champions, 2nd among all industries and companies in Türkiye, mong the companies making the highest investment in R&D, according to the Turkishtime R&D 250 Survey, and 1st in the pharmaceutical industry for the number of national patents.